Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide
The major potential adverse effect of use of sulfonylurea agents (SUAs) is a hyperinsulinaemic state that causes hypoglycaemia. It may be observed during chronic therapeutic dosing, even with very low doses of a SUA, and especially in older patients. It may also result from accidental or intentional...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2005
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414034/ |